Why Read “The Tan Sheet”?
“The Tan Sheet” is the OTC industry’s leading source of business and regulatory news and analysis, covering business and marketing news, such as Rx-to-OTC switches; product testing; new product introductions and advertising; financial and trademark news; and oversight and regulatory activities of Congress, FDA, FTC, CPSC and self-regulatory agencies. More than just headlines, “The Tan Sheet" provides expert analysis of what new developments and regulations actually mean for your company’s bottom line, utilizing its dedicated staff of experienced, on-the-ground analysts and their extensive connections in Congress and the industry.
Who Reads “The Tan Sheet”?
Executives, marketers, consultants and investors who need business and regulatory coverage of the non-prescription pharmaceutical (OTC) and nutritional industries count on “The Tan Sheet" to help them monitor a highly competitive marketplace; develop marketing and advertising plans and profitable business development strategies; identify potential competitors, partners and investors; and prevent unpleasant regulatory surprises.
Subscription Terms
Subscription Options
Buy Now
Includes:
Email newsletter with latest headlines, breaking news alerts, and access to “The Tan Sheet” — in-depth news and analysis of the nonprescription pharmaceutical and dietary supplement industries.
Multiple users/site features: Contact Deanna Flanick at +1-908-547-2141 or D.Flanick@Elsevier.com.